Investor Eye: Endeavour Vision Highlights Humanity Of Medtech, Invests In Unmet Needs
Executive Summary
Unmet needs are at the core of Endeavour Vision’s investment strategy, accepting that payment models may need to change as patients become more directly involved in device development.
You may also be interested in...
Investor Eye: Juno Capital Believes Medtech Is An Optimal Long-Term Investment
Juno Capital partner Edward Rudd believes that investing in medtech offers not only a long-term strategy for allocating capital, but an altruistic relief for investors.
Digital Health Start-Ups Continue To Be Attractive SPAC Targets
According to Rock Health, 52 health-care focused SPACs are looking for targets. This comes as blank check companies are facing rising scrutiny by regulators.
Liquid Biopsy Revolutionizing Cancer Care, But Costs Continue To Inhibit Global Potential
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.